Reduced Growth in Response to Ganciclovir Treatment of Subcutaneous Xenografts Expressing HSV-tk in the Vascular Compartment

Gene Therapy - United Kingdom
doi 10.1038/sj.gt.3301483
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Construction and Characterization of Recombinant HSV-1 Expressing Early Growth Response-1

ISRN Virology
2014English

In Vitro Synergism of Trifluorothymidine and Ganciclovir Against HSV-1

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2011English

Selection of HSV-1 TK Gene-Transfected Murine Mammary Carcinoma Cells Resistant to (E)-5-(2-Bromovinyl)-2′-Deoxyuridine (BVDU) and Ganciclovir (GCV)

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2000English

The Anti-Glioma Effect of Suicide Gene Therapy Using BMSC Expressing HSV/TK Combined With Overexpression of Cx43 in Glioma Cells

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2009English

Xenografts in Septic Vascular Surgery

Gefasschirurgie
SurgeryCardiovascular MedicineCardiology
2016English

Response of Anaemia in Rheumatoid Arthritis to Treatment With Subcutaneous Recombinant Human Erythropoietin.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1992English

Association of ARMS2 Genotype With Response to Anti-Vascular Endothelial Growth Factor Treatment in Polypoidal Choroidal Vasculopathy

BMC Ophthalmology
MedicineOphthalmology
2017English

Homing in on the Cellular Immune Response to HSV-2 in Humans*

American Journal of Reproductive Immunology
2005English

HSV-tk Gene Therapy for Human Renal Cell Carcinoma in Nude Mice

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy